A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.
2010-03
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.
Authors
Published Date
2010-03
Publisher
Type
Thesis or Dissertation
Abstract
The canonical Wnt signaling pathway has emerged as an important regulator of bone formation, regeneration and repair. Studies over the past decade have demonstrated that activation of canonical Wnt signaling generally promotes osteoblast proliferation and enhances bone mass, while suppression of Wnt signaling results in bone loss. Gaining a better understanding of Wnt signaling in the context of skeletal metabolism is important because current skeletal regeneration and repair treatments have limitations, anti-resorptive therapies have unknown long-term health consequences and the demand for therapies is rising as our population ages. Osteoporosis is a growing healthcare challenge that affects about 44 million Americans. Cancer survival rates drop drastically in patients suffering from bone metastases. A complete, molecular understanding of the canonical Wnt signaling cascade in the context of skeletal biology will promote the development of new therapies for the treatment of osteoporosis, skeletal cancer metastasis, and other skeletal diseases that result in uncoupling of bone formation and resorption.
Lymphoid Enhancer Binding Factor (Lef) 1 is a transcription factor in the canonical Wnt/The canonical Wnt signaling pathway has emerged as an important regulator of bone formation, regeneration and repair. Studies over the past decade have demonstrated that activation of canonical Wnt signaling generally promotes osteoblast proliferation and enhances bone mass, while suppression of Wnt signaling results in bone loss. Gaining a better understanding of Wnt signaling in the context of skeletal metabolism is important because current skeletal regeneration and repair treatments have limitations, anti-resorptive therapies have unknown long-term health consequences and the demand for therapies is rising as our population ages. Osteoporosis is a growing healthcare challenge that affects about 44 million Americans. Cancer survival rates drop drastically in patients suffering from bone metastases. A complete, molecular understanding of the canonical Wnt signaling cascade in the context of skeletal biology will promote the development of new therapies for the treatment of osteoporosis, skeletal cancer metastasis, and other skeletal diseases that result in uncoupling of bone formation and resorption.
Lymphoid Enhancer Binding Factor (Lef) 1 is a transcription factor in the canonical Wnt/Lrp5/6/β-catenin signaling cascade, which regulates osteoblast differentiation, bone density and skeletal strength. In this thesis, I describe the expression and function of an alternative Lef1 isoform in osseous cells. Lef1ΔN is a naturally occurring isoform driven by a promoter (p2) within the intron between exons 3 and 4 of Lef1. Lef1ΔN is induced during late osteoblast differentiation. This is opposite to the expression pattern of the full-length Lef1 protein, which as we previously showed, decreases during differentiation. We showed that the Lef1ΔN p2 promoter is active in osteoblasts and Runx2 positively regulates its activity. BMP2 also promotes Lef1ΔN expression, whereas Wnt3a represses it. Lef1ΔN overexpression in differentiating osteoblasts induced osteocalcin and type 1 collagen expression, which suggests Lef1ΔN is a crucial regulator of terminal differentiation in osseous cells. We found Lef1ΔN interacts with β-catenin to activate a Lef1-responsive promoter and stimulate the transcription of genes involved in late osteoblast differentiation. We mapped the region of Lef1ΔN that associates with β-catenin to an element within the first 61 amino acids of Lef1ΔN and showed this region was required to induce type 1 collagen and osteocalcin expression during osteoblast maturation. Taken together, Lef1ΔN interacts with β-catenin to regulate terminal differentiation in osseous cells.
Description
University of Minnesota Ph.D. dissertation. March 2010. Major: Microbiology, Immunology and Cancer Biology. Advisor:Jennifer J. Westendorf. 1 computer file (PDF); ix, 136 pages.
Related to
Replaces
License
Collections
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Hoeppner, Luke Hilbert. (2010). A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/61737.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.